IP Library Granted Patent US 7,700,784
Granted Patent B2
US 7,700,784 · App. 10/588,169 · Granted Apr 20, 2010

Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,784
App. No.
10/588,169
Granted
Apr 20, 2010
Kind
B2
Abstract

The present invention relates to a process for the manufacture of intermediates that may be used for the manufacture of ARBs (also called angiotension II receptor antagonists or AT1 receptor antagonists) comprising as a common structural feature a (1H-tetrazol-5-yl)-biphenyl ring.

Claims (20)

1. A process for the manufacture of the compound of formula (I)

wherein Y represents a tetrazole protecting group, and R 1 and R 2 , independently of one another, represent C 1 -C 10 -alkyl, or R 1 and R 2 combined together form C 2 -C 10 -alkylene; comprising reacting an aryl magnesium halide compound of formula (II b)

wherein Hal is chlorine, bromine or iodine, in the presence of a transition metal catalyst and a catalytically effective amount of a metal salt additive, with a compound of formula (II c)

wherein X is a substituent which, when bound to a phenyl ring, is not considerably replaceable at room temperature by an aryl magnesium halide reagent of formula (II b) in the absence of a catalyst; and, if necessary, isolating a resulting compound of formula (I).

2. A process according to claim 1 , wherein an aryl magnesium halide reagent of formula (II b) is prepared by reacting a compound of formula (II a)

wherein R 1 , R 2 and Hal have meanings as defined in claim 1 , with an active form of magnesium in an appropriate solvent.

3. A process according to claim 1 , which process further comprises deprotecting a compound of formula (I) to afford a compound of formula (I A)

4. A process according to claim 1 , wherein variable Y is selected from the group consisting of 1-butoxyethyl, 1-ethoxyethyl, 2-tetrahydropyranyl and 2-tetrahydrofuranyl.

5. A process according to claim 1 , wherein a transition metal catalyst is a complex of a transition metal or a transition metal salt and one, two or up to four coordinating ligands selected from the group consisting of triphenylphosphine, tri(ortho-tolyl)phosphine, tri(para-tolyl)phosphine, trimethylphosphine, triethylphosphine, tributylphosphine, tri(1,1-dimethylethyl)phosphine, tricyclopentylphosphine, tricyclohexylphosphine, trimethylphosphite, triethylphosphite, tri(1-methylethyl)phosphite, tricyclopentylphosphite, tricyclohexylphosphite, 1,2-bis(diphenylphosphino)ethane, 1,3-bis(diphenylphosphino)propane, 1,4-bis(diphenylphosphino)butane, 1,1′-bis(diphenyl -phosphino)ferrocene, 1,1′-bis(di-[2-propyl]-phosphino)ferrocene, 1,1′-bis(di-tert-butyl -phosphino)ferrocene, 1,2-bis(diphenylphosphino)benzene, 2,2′-bis(diphenylphosphino)-1,1′-biphenyl, 2,2′-bis(diphenylphosphino)-1,1′-binaphtyl, bis(2-diphenylphosphinophenyl)ether and 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene.

6. A process according to claim 5 , wherein a transition metal salt is selected from the group consisting of nickel(II) chloride, nickel(II) bromide and nickel(II) acetylacetonate.

7. A process according to claim 5 , wherein a transition metal catalyst is selected from the group consisting of dichlorobis(triphenylphophine)nickel(II), dichloro[1,2-bis(diphenylphosphino)ethane]nickel(II) and dichloro[1,3-bis(diphenylphosphino)propane]- nickel(II).

8. A process according to claim 5 , wherein a transition metal salt is selected from the group consisting of palladium(II) chloride, palladium(II) bromide and palladium(II) acetate.

9. A process according to claim 5 , wherein a transition metal catalyst is selected from the group consisting of dichlorobis(triphenylphophine)palladium(II), dichloro[1,3-bis(diphenylphosphino)propane]palladium(II) and dichlorof[1,1′-bis(diphenylphosphino) -ferrocene]palladium(II), or a dichloromethane adduct thereof.

10. A process according to claim 1 , wherein a metal salt additive is selected from the group consisting of a copper(I), copper(II), zinc(II), silver(I), cadmium(II), mercury(II), aluminum(III), gallium(III), indium(III), tin(IV), titanium(IV) and zirconium(IV) salt.

11. A process according to claim 10 , wherein the amount of metal salt additive used is between 0.1 and 8 molar % relative to a compound of formula (II c).

12. A process according to claim 1 , wherein X is chlorine; and a transition metal catalyst is a complex of nickel(0), or a complex of nickel(II) salt with at least one organophosphorus compound containing trivalent phosphorus; or a transition metal catalyst is a nickel(II) complex with an organophosphorus ligand which contains two trivalent phosphorus atoms.

13. A process according to claim 12 , wherein a transition metal catalyst is dichloro[1,2-bis(diphenylphosphino)ethane]nickel(II); and a metal salt additive is ZnCl 2 or ZnBr 2 .

14. A process according to claim 1 , wherein X is bromine; and a transition metal catalyst is a complex of palladium(0), or a complex of a palladium(II) salt with at least one organophosphorus compound containing trivalent phosphorus; or a transition metal catalyst is a palladium(II) complex with an organophosphorus ligand which contains two trivalent phosphorus atoms.

15. A process according to claim 14 , wherein a transition metal catalyst is dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II), or a dichloromethane adduct thereof; and a metal salt additive is ZnCl 2 or ZnBr 2 .

16. A process according to claim 1 , wherein a transition metal catalyst is an uncomplexed transition metal which is selected from the group consisting of nickel, palladium, platinum, cobalt, manganese or copper; or wherein a transition metal catalyst is an uncomplexed transition metal salt which is selected from the group consisting of nickel(II), palladium(II), platinum(II), cobalt(II), manganese(II), copper(I) or copper (II) chloride, bromide, iodide, hydroxide, oxide, acetate, hydroxyacetate, propionate, succinate, trifluoroacetate, acetylacetonate, nitrate, cyanide, sulfate, trifluoromethanesulfonate, methanesulfonate, benzenesulfonate or p-toluenesulfonate thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 026002/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2010
From: KRELL, CHRISTOPH; HIRT, HANS
To: NOVARTIS AG
Reel/Frame 023840/0991 →